SCHEMBL4374387

SCHEMBL4374387

C#Cc1ccc(N(C)C(=O)O)nc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR4 P22455 1/20 0.43
USP30 Q70CQ3 2/20 0.36
HCAR3 P49019 2/20 0.36
EGLN1 Q9GZT9 1/20 0.35
JAK2 O60674 1/20 0.35
JAK3 P52333 1/20 0.35
PARP1 P09874 1/20 0.33
F10 P00742 1/20 0.33
FFAR1 O14842 1/20 0.32
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
GRM5 P41594 1/20 0.31
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA4 P22748 1/20 0.31
CA9 Q16790 1/20 0.31
CA14 Q9ULX7 1/20 0.31
GABRA1 P14867 1/20 0.30
GABRG2 P18507 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4370754 0.80 FFAR1 (0.35) USP30HCAR3FFAR1GRM5GABRA1
SCHEMBL15378607 0.80 FGFR4 (0.36) FGFR4HCAR3EGLN1JAK2JAK3
SCHEMBL15950272 0.79 GABRG2 (0.41) FGFR4USP30JAK2JAK3GRM5
SCHEMBL2545907 0.78 ADK (0.40) FGFR4JAK2JAK3GRM5
SCHEMBL25382866 0.75 KDM4E (0.34) FGFR4HCAR3
SCHEMBL2099047 0.74 GBA1 (0.50) HCAR3MEN1KMT2A
SCHEMBL15173773 0.74 HCAR3 (0.38) HCAR3JAK2MEN1KMT2A
SCHEMBL477388 0.74 HCAR3 (0.38) USP30HCAR3MEN1KMT2ACA12
SCHEMBL691857 0.71 HCAR3 (0.46) USP30HCAR3MEN1KMT2AGABRA1
SCHEMBL3463002 0.71 USP30 (0.53) USP30MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023163033-A1 NOVEL COMPOUND, α-SYNUCLEIN AGGREGATE BINDER, AND USE THEREOF 国立研究開発法人量子科学技術研究開発機構 2023-08-31 WO disclosed
WO-2009117421-A2 HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE KALYPSYS, INC. (US) 2009-09-24 WO disclosed